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Abstract
Telomere maintenance is essential to ensure proper size and function of organs with a high turnover. In particular, a dwarf
phenotype as well as phenotypes associated to premature loss of tissue regeneration, including the skin (hair loss, hair
graying, decreased wound healing), are found in mice deficient for telomerase, the enzyme responsible for maintaining
telomere length. Coincidental with the appearance of these phenotypes, p53 is found activated in several tissues from these
mice, where is thought to trigger cellular senescence and/or apoptotic responses. Here, we show that p53 abrogation
rescues both the small size phenotype and restitutes the functionality of epidermal stem cells (ESC) of telomerase-deficient
mice with dysfunctional telomeres. In particular, p53 ablation restores hair growth, skin renewal and wound healing
responses upon mitogenic induction, as well as rescues ESCmobilization defects in vivo and defective ESC clonogenic
activity in vitro. This recovery of ESC functions is accompanied by a downregulation of senescence markers and an increased
proliferation in the skin and kidney of telomerase-deficient mice with critically short telomeres without changes in apoptosis
rates. Together, these findings indicate the existence of a p53-dependent senescence response acting on stem/progenitor
cells with dysfunctional telomeres that is actively limiting their contribution to tissue regeneration, thereby impinging on
tissue fitness.
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Introduction
The mechanisms that dictate body size and frailty of organisms
are still poorly understood. One determinant of both biological
traits is proposed to be the number of functional stem cells within
tissues as stem cells are crucial in generating, regenerating and
maintaining tissues throughout organism life span [1,2]. In support
of this notion, a number of signaling pathways have been
described that when activated result both in increased organ size
and expanded stem/progenitor cell pools, such as components of
the IGF-1 and the Hippo/YAP pathways [3–5]. In contrast,
overall body size reduction, stem cell dysfunction and organ failure
are hallmarks of the elderly [6]. Similarly, mice showing growth
retardation and premature aging phenotypes also have decreased
numbers of functional stem cells within tissues [7]. Together, these
findings suggest that occurrence of reduced organismal size and
tissue dysfunction are likely linked to the exhaustion of functional
stem cell pools, in agreement with a ‘‘rate-of-living’’ theory of
aging specifically acting on stem cells [8].
Telomere shortening has been shown to affect both organismal
size and stem cell functionality in the context of telomerase-deficient
mice [9]. Telomeres are ribonucleoprotein complexes at the ends of
eukaryotic chromosomes that have an essential role in protecting
chromosome ends for DNA repair and degrading activities [10–13].
A minimal number of TTAGGG tandem repeats and the integrity
of a six-protein complex known as shelterin are required to ensure
telomere protection [14]. If telomere function is compromised, i.e.,
by altering shelterin components or by severe telomere erosion, a
robust DNA damage response is activated leading to cellular
senescence and/or apoptotic responses [15,16]. Interestingly, an
age-dependent accumulation cells with damaged telomeres (ie, cells
showing co-localization of gamma-H2AX foci and telomeres) has
been reported in primates, suggesting that telomere dysfunction may
act as a chronological clock [17]. In this regard, telomere shortening
occursassociated to mouseand human aging andhasbeenproposed
to be rate-limiting for organismal life span [18–20]. Importantly,
telomere shortening associated with aging is observed both at stem
cell and differentiated compartments in humans and mice [18,19],
opening the possibility that telomere erosion with age may be
responsible, at least in part, for the decline in stem cell functionality
associated to the aging process [20,21]. This notion is supported by
telomerase-deficient mice with short telomeres, which show severely
compromised epidermal stem cell functionality with increasing
mouse generations [9]. Likewise, severe telomere attrition in these
mice leads to the occurrence of a dwarf phenotype [9].
The tumor suppressor protein p53 is activated and mediates the
cellular response to various types of DNA damage, including
telomere dysfunction [22,23]. In particular, abrogation of p53
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short telomeres, suggesting that p53 senses telomere damage in
stem/progenitor cell populations and leads to massive germ cell
apoptosis [24,25]. In turn, p53 abrogation also impairs the tumor
suppressor activity of short telomeres leading to increased
tumorigenesis in telomerase deficient mice simultaneously lacking
p53 [25,26].
Here, we set to address the role of p53 in both organismal size
determination and in epidermal stem cell (ESC) behavior (ESC
mobilization and clonogenic activity, wound healing, hair growth,
skin regeneration) in mice with dysfunctional telomeres by
generating doubly deficient mice for telomerase and p53, Terc
2/
2p53
2/2. We found that p53 ablation rescues the mitogen
induced hair and skin growth responses, at the same time that it
corrects ESC activation and the dwarf phenotype of late-
generation telomerase deficient mice. All together, these findings
support the notion that p53 plays a central role in limiting the
functionality of epidermal stem cells as well as in restricting
organismal size in mice with dysfunctional telomeres.
Results and Discussion
p53 abrogation rescues epidermal and hair growth
defects in telomerase-deficient mice with short
telomeres
The skin is one of the tissues where the pro-aging effects of short
telomeres are more clearly visible in the context of telomerase-
deficient mice [27]. In particular third generation (G3) Terc
2/2
mice show a delay in wound closure and a stunted hair growth
response after mitogen induction [9,27]. These skin defects are
further aggravated at old ages leading to severe premature
alopecia and hair graying in late generation Terc
2/2 [27]. Here,
we set to address whether p53 activation in response to short
telomeres contributes to defective skin and hair regeneration by
limiting ESC functionality. To this end, we generated increasing
generations of mice doubly deficient for Terc and p53 reaching
third generation (G3) Terc
2/2p53
2/2 mice, as well as the
corresponding G3 Terc
2/2p53
+/+ littermate controls (see Methods
for breeding strategies). First, we assessed the role of p53 in the
impaired wound healing response associated to critically short
telomeres [27] To this end, three consecutive punch biopsies were
performed on dorsal skin of age-matched (2-months old) G3
Terc
2/2p53
2/2 and G3 Terc
2/2p53
+/+ littermates, as well as wild-
type controls (Methods). The rate of wound healing was monitored
as the percentage of the initial wound area left open at different
times after the wound was made (Methods). One wound was
created 2 days after the other and the animals were killed 6 days
after the last wound was made. As previously reported for middle-
age telomerase-deficient mice, young G3 Terc
2/2p53
+/+ mice
exhibited a delay in wound closure (Fig. 1a–c), with average
wound areas at day 3 of 26% and 67% for wild type mice and G3
Terc
2/2p53
+/+ mice, respectively (p=0.013) and 6% and 43% for
wild type mice and G3 Terc
2/2p53
+/+ mice, respectively at day 6
(p,0.001; Fig. 1a–c). Interestingly, we observed a partial recovery
to normal wound healing rates in the case of G3 Terc
2/2p53
2/2.
At day 3, only 46% of the initial wound area persists, which is
further decreased to 17% three days later (Fig. 1a–c). Taken
together, these results indicate that the skin of G3 Terc
2/2p53
2/2
mice presents a faster wound-healing rate than that of the
corresponding G3 Terc
2/2p53
+/+ littermates, supporting an
inhibitory effect of p53 in the wound healing process in mice
with short telomeres.
We next assessed the role of p53 in the impaired hair growth
response associated to critically short telomeres. Hair follicle (HF)
length and inter-follicular (IFE) skin thickness were not signifi-
cantly increased in G3 Terc
2/2p53
+/+ mice upon TPA treatment
(Fig. 1d,e), in agreement with a defective ESC functionality in
these mice [9]. Strikingly, p53 abrogation rescued the defective
hair growth response as well as the epidermal hyperplastic
response in G3 Terc
2/2p53
2/2 mice to a similar extend than
that of wild-type mice, as indicated by significantly increased HF
length and IFE thickness in response to TPA treatment compared
to control ‘‘resting’’ non-treated skin (Fig. 1d,e). This finding
indicates that p53 deletion can restore both hair growth and
epidermal defects in mice with short telomeres to wild-type levels,
suggesting the existence of a p53-dependent checkpoint that is
limiting the entry of hair follicles in the anagen (growing) phase of
the hair cycle in the presence of critically short telomeres.
Unfortunately, early death of G3 Terc
2/2p53
2/2 cohorts due to
an early onset of lymphomas and sarcomas associated to p53-
deficiency (ie., all mice were dead with in the first 40 weeks of life;
not shown) prevented the analysis of the role of p53 in additional
skin defects associated to critically short telomeres, such as hair
graying and alopecia [27,28].
p53 ablation restores tissue mobilization of ESC
harbouring dysfunctional telomeres
Considering the important contribution of stem cells to organ
development and tissue fitness, we next addressed whether the
ability of ESC to regenerate skin and the hair was limited by p53
in the presence of short/dysfunctional telomeres. First, we
examined whether p53 accumulates in skin cells from late
generation telomerase-deficient mice. As shown in Fig. 2a, we
found a significant number of p53-positive cells in the skin of G3
Terc
2/2 mice after TPA treatment, which were rarely observed in
the corresponding age-matched TPA-treated wild-type controls
(Fig. 2a, see Fig. 2b,c for quantification). Interestingly, the majority
of p53-positive cells were located at the hair bulge and their close
proximity, as well as we detected patches of p53-positive cells at
the basal layer of the epidermis (Fig. 2a–c), known locations for
stem/progenitor cells in mouse epidermis [29,30] , suggesting that
p53 is activated in stem/progenitor cells in the presence of short
telomeres. Next, to visualize and study the behavior of epidermal
stem cells, we used a labeling technique previously shown to mark
self-renewing and multi-potent epidermal cells, the so-called ‘‘label
retaining cells’’ (LRCs) (Methods and Methods S1) [31,32].
Confocal microscopy of skin whole-mounts revealed that LRCs
accumulated at the bulge area of the hair follicle in all the
examined genotypes, in agreement with the known location of the
hair follicle stem cell niche [9,33–36] (Fig. 3a, see also Fig 2).
Interestingly, in resting-skin conditions both G3 Terc
2/2p53
2/2
and G3 Terc
2/2p53
+/2 hair follicles contained significantly less
LRCs compared to G3 Terc
2/2p53
+/+ follicles, indicating a higher
rate of label disappearance in G3 Terc
2/2 cells, which is associated
with decreasing p53 gene levels (Fig. 3a,b). This finding suggests
that p53 gene dosage is rate limiting in detecting telomere damage
and that G3 Terc
2/2p53
2/2 and G3 Terc
2/2p53
+/2 keratinocytes
are more prone to exit the stem cell niche and to proliferate than
G3 Terc
2/2p53
+/+ keratinocytes. Despite the above differences in
LRC numbers in resting conditions, we have not detected
significant alterations on the hair cycle stage between G3 Terc
2/2
p53
2/2,G 3Terc
2/2p53
+/2 and G3 Terc
2/2p53
+/+ animals
(Fig 1b,c and data not shown). To specifically assess whether
ESC activation differs between the different genotypes, the skin
was treated with TPA as previously described (Methods). Upon
TPA treatment, only 28% of G3 Terc
2/2p53
+/+ LRCs were
activated (calculated as percentage LCR decrease at the hair bulge
following TPA treatment compared to the resting-skin control),
p53 Restricts Skin Stem Cells
PLoS ONE | www.plosone.org 2 March 2009 | Volume 4 | Issue 3 | e4934confirming a defective ESC activation in Terc
2/2 mice with short
telomeres (Fig. 2a,b) [9]. Furthermore, in agreement with a
defective mobilization of G3 Terc
2/2p53
+/+ ESC, scattered LRC
are still detectable within the infundibulum and basal layer of the
IFE, which could partially explain why the infundibulum and the
IFE did not thicken following TPA treatment (Fig. 2a). In contrast,
up to 35% of LRCs from TPA-treated G3 Terc
2/2p53
+/2 were
activated. This mobilization response was even more pronounced
in the case of G3 Terc
2/2p53
2/2 mice reaching a similar
activation level to that previously described for wild-type ESC of
the same genetic background (70% activation; Fig. 3a,b) [9].
Concomitant with the restoration of the ESC activation response,
the absence of p53 was accompanied by a clear enlargement of the
transient amplifying compartments of G3 Terc
2/2p53
2/2 mice
(Fig. 3a,b). These results indicate that p53 dosage influences ESC
behavior of mice harboring critically short telomeres, leading to
normal activation responses when p53 is absent.
p53 ablation increases the clonogenic activity of ESC
with short telomeres
We previously described that ESC derived from late generation
telomerase-deficient mice with short telomeres have a decreased
proliferation potential when cultured ex vivo using the so-called
clonogenic assays [9] (Methods and Methods S1). The number
and size of colonies in these assays is proposed to reflect on the
proliferation potential of individual ESCs [37]. Furthermore,
Figure 1. p53 deletion rescues epidermal and hair growth responses in late-generation telomerase-deficient mice. (A) Wound healing
of wild-type, G3 Terc
2/2 and G3 Terc
2/2p53
2/2 skin. (B) Percentage of initial wound area left at the indicated days after the punch was created. Three
wounds were created per mouse, and the total number of wounds per genotype is indicated in the graph (n). (C) Statistical analysis showing that the
healing rate is significantly different between genotypes is also shown (p-values). Bottom: Representative images of wounds 4 days after the first
wound was made (1, 2 and 3 in the figure correspond to the first, second and third wound at 4, 2 and 0 days, respectively, after the first wound was
created). (D) Representative tail-skin sections from wild-type, G3 Terc
2/2 and G3 Terc
2/2p53
2/2 littermates before and after TPA-treatment.
Continuous black double-point arrows mark inter-follicular (IFE) thickness. Black dashes double-point arrows mark hair follicle (HF) length. (E)
Quantification of the HF length (bottom) and IFE thickness (top). Histomorphometry was performed in three mice of each genotype (n), quantifying
30 hair follicles (HF) per group. Note the increased HF length and epidermis thickness in TPA-treated wild-type and G3 Terc
2/2p53
2/2 mice,
compared with a defective response in TPA-treated G3 Terc
2/2 animals. Scale bar, 50 mm.
doi:10.1371/journal.pone.0004934.g001
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derive from single ESCs [37]. Here, we set to address whether
absence of p53 rescues the decreased clonogenic activity of ESC
with short telomeres. To this end, we performed clonogenic assays
with newborn keratinocytes isolated from G3 Terc
2/2p53
2/2 and
G3 Terc
2/2p53
+/+ mice, as well as the corresponding wild-type
controls (Methods). Interestingly, G3 Terc
2/2p53
2/2 cells showed
a similar clonogenic potential to that of wild-type cells, while G3
Terc
2/2p53
+/+ cells were severely affected (see number and size of
colonies in Fig. 4a,b), indicating that p53 abrogation fully rescues
the proliferation potential of ESCs with short/dysfunctional
telomeres ex vivo. All together, these results indicate that p53
ablation rescues both the cell-autonomous ESC proliferation
defects (Fig. 4), as well as the in vivo ESC ‘‘mobilization’’ defects
(Fig. 3a,b) in mice with critically short telomeres.
p53 abrogation rescues the ‘‘small-size’’ phenotype of
mice with critically short telomeres
It has been speculated that stem cells have a role in setting the
size of organs as well as of the whole organism (see Introduction).
Figure 2. p53
high positive cells in late-generation telomerase-deficient mice are found preferentially at the hair bulge after TPA
stimulation. (A) Immunohistochemistry was performed with anti-p53 antibodies in tail skin for wild type and G3 Terc
2/2 mice before and after TPA
treatment. Positive cells with a clear staining for p53 were found scattered within the bulge, the hair follicle stem cell compartment, and their close
proximity in G3 Terc
2/2 animals upon TPA stimulation as well as in patches within the basal layer (see red arrows points, left panels). Hair bulge
compartment has been defined by CD34 and keratin15 positive staining in addition to accumulation of LRCs. Inserts: high magnification images
showing the bulge area. Black arrows points to p53
high positive cells. Number of p53 positive cells at the hair follicle (B) and interfollicular epidermis
(IFE) (C) in the conditions and genotypes shown in (A).
doi:10.1371/journal.pone.0004934.g002
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G3 telomerase-deficient mice show a reduction in body size at the
time of birth (telomerase-deficient dwarf mice), which is associated
with the appearance of critically short telomeres [9]. Interestingly,
both in vivo and ex vivo ESC activation defects and TPA-stimulated
p53 induction are milder when G3 Terc
2/2 mice with standard
body size are examined (Figure S1 and [9] further substantiating
the link between the proliferation potential of stem cells and
organismal size. Furthermore, we previously described that the
dwarf phenotype of telomerase-deficient mice can be rescued by
telomerase re-introduction, demonstrating that this phenotype
directly provoked by the presence of critically short telomeres
[9,38].Given the above-described role for p53 in limiting the
contribution of adult stem cells with dysfunctional telomeres to
tissue regeneration and ESC proliferation ex vivo, we sought to
assess whether p53 abrogation could also restore a normal body
size in telomerase-deficient mice with critically short telomeres,
arguing for a more global role of p53 in controlling stem cell
behavior by signaling DNA damage associated to dysfunctional
telomeres. To address this, we generated fourth generation (G4)
Terc
2/2 mice, which show a 100%-penetrance of the dwarf
phenotype when in a C57BL6 background (see Fig. 5a). As shown
in Fig. 5a,b, genetic ablation of p53 rescued a normal body size
and weight of G4 Terc
2/2p53
2/2 at time of birth, which was
indistinguishable to that of wild-type controls, suggesting that
critically short telomeres in these mice are limiting body size.
These findings argue that critically short telomeres can activate
p53 during mouse development, which in turn limits the net
expansion of tissues.
p53 ablation reduces the growth arrest/senescence
response in the skin and kidney of mice with critically
short telomeres
The fact that G4 Terc
2/2p53
2/2 newborns reach standard
body size and weight suggests that p53 deficiency enables G4
Terc
2/2p53
2/2 cells to enter into additional rounds of cell
proliferation in the presence of critically short telomeres, a
situation that resembles the known effects of p53 ablation in
bypassing cellular senescence both in vivo and in vitro [24,39,40].
However, whether a p53-dependent cellular senescence and/or
apoptosis response contributes to set organ and organismal size
during embryonic development, or to limit stem cell functionality
in adult tissues, remains unaddressed to date. To further analyze
the consequences of increased p53 in mice with critically short
Figure 3. p53 loss rescues the hair follicle stem cell activation response in late-generation telomerase-deficient mice. (A and B)T o
assay for LRC activation, G3 Terc
2/2 and G3 Terc
2/2p53
2/2 littermates were injected with repetitive pulses of BrdU and, after 69 days, whole mounts
of tail epidermis were collected from untreated and TPA-treated mice and stained with a BrdU antibody. (A) Representative confocal micrographs of
tail follicles from G3 Terc
2/2 ,G 3Terc
2/2p53
+/2 and G3 Terc
2/2p53
2/2 mice stained for BrdU (green) before (control) and after (TPA) TPA treatment.
(B) Number of LRCs in the conditions and genotypes shown in (A). LRCs numbers were calculated in (n) number of mice of each genotype,
quantifying at least 26 hair follicles (HF) per group. Note a higher percentage of LRCs activation in TPA-treated G3 Terc
2/2p53
2/2 and G3 Terc
2/2
p53
+/2 mice compared with G3 Terc
2/2 mice. For comparison purposes, LRCs activation in TPA-treated G3 Terc
2/2p53
2/2 mice reached 81% (81%
decrease in LCRs following TPA treatment compared to resting non-treated controls), which is similar to that previously described for wild-type ESC
of the same genetic background (70% activation; Flores et al., 2005). LCR activation is calculated as percentage LCR decrease at the hair bulge
following TPA treatment compared to the resting-skin (control). Scale bar, 80 mm.
doi:10.1371/journal.pone.0004934.g003
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mice with a reduced body size (G3 Terc
2/2) enter senescence or
undergo apoptosis in a p53-dependent manner. Senescence is
associated with a decline in proliferation that culminates in a
permanent arrest of the cell cycle [41]. Therefore, we first
compared the ability of G3 Terc
2/2 keratinocytes to proliferate in
the presence or absence of p53. As shown in Fig 6a,b, we detected
slightly fewer Ki67-positive keratinocytes in G3 Terc
2/2p53
+/+
untreated interfollicular (IFE) skin compared to G3 Terc
2/2p53
2/2
or wild type skin, although the differences did not reach statistical
significance. In contrast, a marked reduction in proliferation (Ki67-
positive cells) is observed in TPA-treated G3 Terc
2/2p53
+/+ skin
when compared with TPA-treated G3 Terc
2/2p53
2/2 and TPA-
treated wild type controls (Fig. 6a,b), suggesting that the defective
proliferation response to TPA of G3 Terc
2/2 keratinocytes is
mediated by p53. In addition to growth arrest, senescence is
associated at the molecular level with enhanced expression of the
p53-transcriptional target p21WAF1 [41]. In resting skin condi-
tions, a faint p21 expression was observed in G3 Terc
2/2p53
+/+
epidermis, which becomes overtly visible after TPA treatment
(Fig. 6c,d). Similarly to that observed for p53 expression in G3
Terc
2/2p53
+/+ epidermis, positive-p21cells located at the hair bulge
and its close proximity, suggesting that the p53 transcriptionaly
target p21 becomes active in stem/progenitor cells with short
telomeres upon enforced proliferation. In addition, p21 expression
was barely detectable at the bulge of wild type and G3 Terc
2/2
p53
2/2 hair follicles further (Fig. 6c,d), indicating that in the hair
bulge the induction of p21 is mediated by p53. In other epidermal
compartments, such as the hair bulb, infundibulum and IFE, a
TPA-mediated p21 induction was observed regardless of p53 gene
status (Fig. 6c,d), which suggest a minor role of p53 on the p21
upregulation in the above compartments in agreement with
previous reports [42]. Next, we examined the kidney, an organ in
which p53 loss partially rescues a senescence-associated phenotype
induced by nuclear damage [43]. Similarly to the results obtained in
keratinocytes, we detected a marked reduction in Ki67-positive
cells, which was accompanied by p21-upregulation in G3 Terc
2/2
renal cells compared to wild types (Fig. 6e,f). In addition, we
observed numerous G3 Terc
2/2 renal cells harboring senescence-
associated ß-galactosidase activity (Fig 6e,f). Importantly, both
proliferative defects and senescence markers are rescued in the
absence of p53 (Fig. 6e,f), indicating the importance of p53 in
mediating cellular arrest and senescence in response to short
telomeres. Finally, absence of active caspase 3- and TUNEL-
Figure 4. p53 abrogation rescues the proliferation potential of epidermal stem cells in late-generation telomerase-deficient mice.
(A) Representative images of number and size of macroscopic colonies obtained from isolated keratinocytes from wild-type, G3 Terc
2/2 and G3
Terc
2/2p53
2/2 littermates. Note more abundant and larger colonies in wild-type and G3 Terc
2/2p53
2/2 compared with G3 Terc
2/2. Individual
colonies in this assay have been proposed to derive from single ESC [37]. (B) Quantification of size and number of macroscopic colonies obtained
from isolated keratinocytes from the indicated genotype purified from a total of 3 independent 2-days old mice and cultured for 1 week on J2-3T3
mitomycin C-treated feeder fibroblast.
doi:10.1371/journal.pone.0004934.g004
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apoptosis in the observed phenotypes, in agreement with previously
published data [9] (Fig. 6g,h). Taken together, these findings
strongly suggest the presence of a p53-dependent senescence
response acting on stem/progenitor cells with dysfunctional
telomeres, which in turn limits their contribution to tissue size and
fitness.
Final remarks
In summary, our results define a role for the tumor suppressor
p53 in monitoring ESC quality, so that ESC with dysfunctional
telomeres cannot contribute to regeneration of the skin and hair,
by virtue of activating a p53-dependent checkpoint. This
checkpoint may be particularly important to maintain tissue
fitness by ensuring that only those stem cells with a functional
telomere length will contribute to tissue regeneration and tissue
function. In addition, we show here that p53 ablation completely
rescues a normal (indistinguishable to that of wild-type controls)
organismal size at time of birth without any detectable short–term
adverse effects on these mice, suggesting the existence of an early
p53-mediated checkpoint controlling organismal size during
embryonic development. A related early checkpoint limiting stem
cell function and lifespan of mice with dysfunctional telomeres has
been recently described to involve p21, a downstream target of
p53 [44]. Interestingly, given the fact that p53 deletion in mice
with short telomeres eventually leads to accelerated tumor
formation, the premature nature of the p53-mediated blockage
on stem cell activation in these mice could serve as an ahead-of-
time crucial first barrier against tumor progression. Alternatively,
taking into account unexpected recent findings showing little
impact of DNA damage-activated p53 in cancer protection
[45,46], an intriguing possibility emerges that p53 inhibition in
the case of mild DNA/telomere damage could overall resolve in
beneficial effects. Finally, given that the absence of p53 seems to
exert a general effect on mice, as indicated by the fact that the
small body size phenotype is completely rescued in G4 Terc
2/2
p53
2/2 mice, these results suggest that p53 abrogation could
conceivably restitute stem cells functionality in other organs
harboring short telomeres.
Methods
Animals and treatment regimens
Terc
+/2 and p53
+/2 mice were first intercrossed to generate
Terc
+/2p53
+/2 double heterozygous mice and then mated to
generate first generation (G1) Terc
2/2p53
+/2 littermates. G1
Terc
2/2p53
+/2 littermates were interbreed for successive genera-
tions to obtain late generation G3–G4 Terc
2/2p53
2/2 double
mutant mice as well as their G3–G4 Terc
2/2 littermate controls
[25]. The genetic background for all genotypes was a pure
C57BL6 background.
To induce LRC mobilization, IFE hyperplasia and hair growth,
tail skin from a group of three 71-days-old mice per genotype in
the resting phase of the hair cycle was topically treated every
48 hours with TPA (20 nmol in acetone) for four doses with the
exception of the experiments represented in Fig. 2, Fig. 6 and
Figure S1a (six doses). Three control mice of each genotype were
treated with acetone alone. 24-hours after the last TPA treatment
skin from a group of three 71-days-old mice per genotype were
sacrificed and the tail skin analyzed.
All animal experiments and husbandry were carried out in
accordance with guidelines from Federation of European
Laboratory Animal Science Association (FELASA).
Wound-healing experiments
Three full-thickness punch biopsies extending through the
epidermisanddermis(punchdiameter4 mm;PFM,Ko ¨ln,Germany)
were performed in three wild-type, three G3 Terc
2/2p53
2/2 and
three G3 Terc
2/2p53
+/+ six K5-mTERT mice (2months of age) after
depilation. Mice were anesthetized prior to wound creation. The
wound-healing rate was calculated as the percentage of initial wound
area with time. Wound areas were calculated with the formula
(area=r
2;w h e r er is the ratio of the wound).
Histology and immunohistochemistry of skin
Tail skin samples were harvested from mice and fixed overnight
in neutral-buffered formalin at 4uC, dehydrated through graded
Figure 5. p53 abrogation rescues the small body-size pheno-
type in late-generation telomerase-deficient mice. (A) Repre-
sentative images of wild-type, G4 Terc
2/2 and G4 Terc
2/2p53
2/2
newborn mice. Note small body size in G4 Terc
2/2 mice compared with
wild-type controls and that small body size is largely rescued in G4
Terc
2/2p53
2/2 mice. (B) Quantification of body weight in wild-type, G4
Terc
2/2 and G4 Terc
2/2p53
2/2 newborn mice. A total of three mice per
genotype were used for the analysis (n).
doi:10.1371/journal.pone.0004934.g005
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of IFE thickness and HF length, dissected skin was cut parallel to
the spine and sections were cut perpendicular to the skin surface in
order to obtain longitudinal HF sections. 5 mM sections were used
for hematoxylin-eosin staining and immunohistochemistry (IHC).
Prior to IHC, slides were de-paraffinized, re-hydrated, immersed
in 10 mM citrate solution and epitopesretrieved by three high-
power, 5 min microwave pulses. Slides were washed in water,
blocked in 1:10 dilution of normal goat serum (Vector Labs) and
incubated with primary antibodies: p53 at 1:150 (CM5p,
Novacastra), CD34 at 1:25 (MEC14.7, Abcam), keratin 15 at
1:25 (LHK15, NeoMarkers), BrdU at 1:35 (BU-1, Amersham), Ki-
67 at 1:200 (SP6, Master Diagnostica), p21 at 1:250 (C-19G; Santa
Cruz Biotechnology) and active caspase-3 at 1:150 (R&D Systems).
Slides were then incubated with secondary biotinylated antibodies
from Vector labs (goat anti-rabbit at 1:200 or goat anti-mouse at
1:200), followed by signal development with an immunoperox-
idase reagent (ABC-HRP, Vector Labs) and DAB (Sigma) as the
substrate. The TUNEL assay was performed using the Apoptag
Kit manufactured by Chemicon. Sections were lightly counter-
stained with hematoxylin and analyzed by light microscopy.
LRC detection
To detect LRCs in whole-mounts, fixed epidermal sheets were
blocked and permeabilized by incubation in a modified PB buffer
[32] containing 0.5% BSA and 0.5% Triton X-100 in TBS for
Figure 6. p53 loss increases the proliferation rate and ameliorates a senescence-associated response in late-generation telomerase-
deficient mice without changes in apotosis rates. Representative tail-skin sections from wild-type, G3 Terc
2/2 and G3 Terc
2/2p53
2/2
littermates stained for Ki-67 (A) and p21 (B) before and after TPA-treatment. Quantification of Ki-67-positive cells in interfollicular epidermis size (C)
and p21-positive cells at the bulge region of hair follicles (D). (E) Representative kidney sections from wild-type, G3 Terc
2/2 and G3 Terc
2/2p53
2/2
littermates stained for Ki-67, p21 and assessed for senescence-associated ß-galactosidase (SA ß-gal) activity. Inserts: high magnification images
showing renal cells assessed for SA-ß-gal activity. (F) Percentage of renal cells positive for Ki-67, p21 and senescence-associated ß-galactosidase
activity. n=number of sections used for quantification. (G) Representative tail-skin sections from wild-type, G3 Terc
2/2 and G3 Terc
2/2p53
2/2
littermates stained for active caspase 3 (top) and TUNEL (bottom) before and after TPA-treatment. (H) Representative kidney sections from wild-type,
G3 Terc
2/2 and G3 Terc
2/2p53
2/2 littermates stained for active caspase 3 (top) and TUNEL (bottom).
doi:10.1371/journal.pone.0004934.g006
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30 min in 2 M HCL at 37uC, incubated overnight with a mouse
anti- BrdU antibody conjugated with fluorescein (Roche) at 1:50 in
modified PB buffer, washed four times in PBS containing 0.2%
Tween 20, and mounted in Vectashield (Vector Labs). Tissues
were then washed as previously described and cover-slipped with
Vectashield with DAPI (Vector Labs).
Colony forming assay
One thousand mouse keratinocytes per genotype isolated from
neonatal skin were seeded onto mitomycin C (10 mg/ml, 2 hours)
treated J2-3T3 fibroblast (105 per well, 6 well dishes) and grown at
37uC/5% CO2 in Cnt-02 medium (CELLnTEC Advanced Cell
Systems AG, Bern, Switzerland). After one week of cultivation,
dishes were rinsed twice with PBS, fixed in 10% formaldehyde and
then stained with 1% Rhodamine B to visualizy colony formation.
Colony size and number were measured using three dishes per
experiment, over a total of three separate experiments.
Statistical analysis
Statistical analysis of differences between different mouse
cohorts was performed using Student t test with ‘‘two tails’’ and
‘‘two-samples of equal variance’’. Microsoft Excel v.X was used for
calculations.
Supporting Information
Figure S1 LRC activation and TPA-mediated p53 induction in
G3 Terc2/2 mice with distinct body sizes. (A) Representative
images of tail-sections from G3 Terc2/2 with a ‘‘small’’ body size
and a ‘‘standard’’ body size stained for p53 before and after TPA-
treatment. (B) Quantification of p53-positive cells that locate to the
hair follicle (left panel) and to the interfollicular epidermis (right
panel). (C) Representative confocal micrographs of tail follicles
from G3 Terc2/2 mice with a ‘‘small’’ body size and a
‘‘standard’’ body size stained for BrdU (green) before (control)
and after (TPA) TPA treatment. (D) Number of LRCs in the
conditions shown in (C).
Found at: doi:10.1371/journal.pone.0004934.s001 (7.09 MB TIF)
Methods S1
Found at: doi:10.1371/journal.pone.0004934.s002 (0.05 MB
DOC)
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